JMP Securities Downgrades ARIAD Pharmaceuticals (ARIA) to Market Perform
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $23.99 --0%
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
JMP Securities downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on ARIAD Pharmaceuticals click here. For more ratings news on ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $9.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades Calix (CALX) to Hold
- Needham Downgrades HashiCorp Inc (HCP) to Hold
- Raymond James Downgrades Northland Power Inc. (NPI:CN) (NPIFF) to Outperform
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
